Pradaxa Lawyers for Severe Bleeding Injuries
Use of the anti-coagulant Pradaxa may significantly increase the risk of serious and potentially fatal bleeding. In 2011, Pradaxa was associated with at least 3,781 injuries and 542 deaths in the U.S. alone. Have you or a loved one suffered from a Pradaxa related injury? If so, contact our knowledgeable drug injury legal team today. We want to help you with your potential pradaxa case.
What is Pradaxa?
Pradaxa is an anti-coagulant, or blood thinner, prescribed to lower the risk of stroke in patients with atrial fibrillation. Almost immediately after entering the market, Pradaxa became associated with serious and life-threatening injuries, including uncontrollable bleeding of the:
Pradaxa: Dangerous from the Start
Within a month of its October 2010 approval date, Pradaxa was linked to more adverse events than 98 percent of the drugs monitored by the FDA, reported MedWatch. A few months later, the FDA had received 120 reports of death among Pradaxa users.
In January 2012, the Archives of Internal Medicine published a study showing that Pradaxa use leads to a 33 percent increased risk of heart attack. Researchers at the Cleveland Clinic evaluated data from more than 30,000 patients and compared Pradaxa to warfarin-based drugs. They found Pradaxa was more likely to cause heart attack.
April 2012 brought an announcement by the European Medicines Agency (EMA). The EMA reviewed Pradaxa and, in response to serious injuries associated with the drug, required Boehringer to provide doctors with clearer guidance for managing Pradaxa risks.
In May 2012, QuarterWatch, a nonprofit organization that monitors FDA reports, announced that Pradaxa was tied for first place among drugs linked to adverse events. In 2011, Pradaxa use was associated with 3,781 injuries and 542 deaths in the U.S., and was considered the highest risk of all prescription drugs for the year. Pradaxa surpassed all other drugs for reported hemorrhage, acute kidney failure and stroke injuries.
Boehringer Ingelheim: Drug Manufacturer Negligence to Blame
Boehringer Ingelheim GmbH should have thoroughly tested Pradaxa in order to warn users of all possible risks. Instead, Boehringer failed to warn patients, doctors and the FDA of the serious bleeding risks and potential for heart attack associated with Pradaxa. Critics allege that Boehringer rushed the testing of Pradaxa in order to market it before competing drugs. Pradaxa was indeed the first to the market — perhaps at the cost of users’ safety.
Boehringer’s negligence is completely unacceptable. Pradaxa users who have been injured or the family of Pradaxa who have died deserve compensation for hospital bills, lost income, costs of future treatment or funeral services, and physical and emotional damage.
Our Pradaxa Injury Attorneys Want to Help
If you have suffered uncontrollable bleeding, or if your loved one lost his or her life due to bleeding after taking Pradaxa, we can help. Contact the attorneys of the Monsour Law Firm for a free case evaluation and consultation to learn more about your legal rights and options. Our experienced drug injury lawyers will work closely with you and fight for the maximum compensation for your injuries.
CALL US TODAY